Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monitoring Prostate Cancer Response with Pylarify PET/MRI
NCT05568537Phase 4Withdrawn
- Sponsor
- Corewell Health
- Start
- Oct 2024
- Primary completion
- Oct 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of piflufolastat f 18 in prostate cancer (PCa), sponsored by Corewell Health. Planned start Oct 2024; status: withdrawn.
02
Drugs
piflufolastat f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT05568537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05568537.